 |
September 2009
|
|
|
|
|
New Business Grant for Biotech
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
NEW BUSINESS GRANT FOR BIOTECH
At BioMelbourne Network's September 2009 monthly BioBreakfast, guests were pleasantly surprised to hear about the launch of a new biotechnology business grant from the Victorian Government. Known as the Biotechnology International Partnering Program, the grant provides financial support for biotechs, up to three times a year, to attend overseas conferences and trade events.
The concept of the grant came out of the Victorian Government’s 2007 Biotechnology Strategic Development Plan, specifically the Competitive Business Evnironment Working Group, comprised of a number of industry volunteers, chaired by Dr Leigh Farrell. The Working Group recognised that biotechs spend considerable funds each year travelling to partnering meetings, sometimes placing a considerable and unavoidable strain on financial resources.
Biotechs can apply for a grant to cover the costs associated with attending an international conference as a participant (up to $2,500), presenting at a conference (up to $3,000), as an exhibitor in a shared stand (up to $4,000) as a sole exhibitor (up to $8,000) and as a first time sole exhibitor (up to $10,000).
This grant is an industry specific grant, exclusing academic and research institutions, distributors and service providers as well as a subsidiary of a foreign company.
The Victorian Government, in particular, the Biotechnology team within the Department of Innovation, Industry and Regional Development, deserve praise for their rapid response to this suggestion and for ensuring the idea was acted upon and generously funded. Well done – an excellent outcome for the industry.
To read the guidelines and apply for the grant go to www.business.vic.gov.au/BUSVIC/GAP/PC_63461.html,svGAP_PC=PC_6346
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
 |
|
|
 |
|
|
Grant Writing Master Class
GRANT WRITING MASTER CLASS
Have you ever raked over government and philanthropic web site searching for grants that might suit your organisation and found the process to be utterly confusing and an excruciatingly frustrating practice ? Are you eligible or not ? Finally you find one, read everything to discover that it closed last week ? Who hasn’t?
A comprehensive grant strategy is somthing that few of us can honestly admit to have developed – a list of relevant funding sources, a calendar of due dates and a review of guidelines and inclusion criteria.
The Grant Writing Master Class on 9 October 2009 at KPMG will give you head start in getting this activity underway for your organisation and a framework to develop future strategies for your organisation.
Government and private grants, philanthropy and scientific grant writing will all be covered as well as the process of researching grants and the actual writing of applications. The presenters will cover average success rates and assessing the potential for success.
Book now !
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
Pharma Partnering Workshop
PHARMA PARTNERING WORKSHOP - CHANGES AT PFIZER, MSD AND GSK
The pharma landscape has seen some very big changes in the past year with some companies moving from “Big Pharma” to “Mega Pharma” as we’ve seen Pfizer merge with Wyeth and MSD acquiring Schering Plough. As the number of traditional players in the world’s pharma industry is decreasing to comprise of a few large pharma companies it becomes more important to hear about what areas they are pursuing in drug development as they steer the pharmaceutical development agenda. GlaxoSmithKline have also reviewed their licensing strategy in a new direction.
To present their new strategies and highlight what pharma want from biotech now, we have the following line up for Pharma Partnering 2009 on 24 September 2009 at Clayton Utz.
Book online now – places limited. http://www.biomelbourne.org/events/view/38
Speakers include:
Dr Daniel Grant
Head of Strategic Alliances
Australia, New Zealand, Singapore
Pfizer Global Research and Development
Pfizer Australia
Dr Phil Kearney
Director - Licensing & External Research
MSD - Australia
Dr Ashley Bates
Head R&D Alliances Australia/NZ
GlaxoSmithKline Australia Ltd
|
|
|
|
 |
 |
 |
|
 |
|
|
|
|
2009 National Preclinical Drug Development Seminar Series
BioSA Incubator, Adelaide, South Australia
21 October 2009
Following successful Brisbane, Melbourne and Sydney seminar / workshops, the 2009 National Preclinical Drug Development Seminar Series will continue in Adelaide.
The full day workshop will be held on Wednesday 21 October 2009 at BioSA Incubator, Adelaide and will focus on 'Getting to the IND'. Participants will work through case studies involving the key phrases of preclinical development including Pre-Pre, Pre-IND and IND.
Topics that will be covered include: Pre-pre-IND phase, Pre-IND phase, IND, preventing clinical holds, choosing the right partners (consultants, service providers), conducting analyses in data, optimising use of resources and more....
|
|
|
|
|
|
Melbourne Convention & Exhibition Centre
Melbourne, Victoria
27 - 30 October 2009
AusBiotech 2009 is the premier biotechnology conference for the Asia Pacific region.
A comprehensive conference program together with an extensive BioIndustry Exhibition and Business Matching Program will bring together representatives from the global biotechnology industry to create a world leading event.
|
|
|
|
 |
|
|
|
|
4th BIO KOREA
COEX, Seoul, Korea
16 - 18September 2009
OVERVIEW:
Expected Exhibitors : Approx. 250 companies
(Approx. 60 from overseas)
Expected Visitors : Approx. 20,000 persons
(Approx. 1,000 from overseas)
Exhibit Categories :
- Pharmaceuticals & Drug Discovery, Biotechnology,
- Genomics & Proteomics
- Industrial & Environmental Biotechnology
- Biochips, Bioelectronics and Bioinformatics
- CRO, CMO, CSO, Patent and Legal Services,
- Venture Capitals, Consulting companies
- Medical Devices & Lab equipments
- BIO-Clusters, Academic Research Centers, etc.
BIO KOREA 2009 OFFERS:
- Exhibition and Company presentation enable you to advertise your company in the globe, especially in Asia Market.
- 1 year round event ensures you to make persistent business partnership.
- Various gathering including receptions provides a practical chance for networking.
- Keynote speeches and seminars inform ongoing trends and news in bio-industry sector.
|
|
|
|
|
|
AAPS Workshop on Quantitative Model-Based Drug Development in Drug Discovery and Translational Research
7 November 2009
Los Angeles Convention Center
Los Angeles, CA, USA
GOALS AND OBJECTIVES:
The area of Preclinical PK/PD Modeling & Simulation encompasses a multitude of quantitative approaches to integrate preclinical pharmacology, bio-marker response and safety data toward the selection of the most promising drug targets and the development of the most optimal drug candidates. In recent years, this rapidly evolving area has been recognized as critical for the pharmaceutical companies to reduce high rates of failures in advancing compounds from the bench to the bedside.
In this one-day workshop, participants will be provided with basic education and hands-on training on technical and theoretical aspects of the preclinical PK/PD modeling via a combination of lectures, case studies and break-out sessions demonstrating the key mathematical strategies to build dose-response relationships, efficacy and human dose projections.
Participants will be:
- Introduced the concept and fundamental principles of PK/PD modeling and simulation, particularly in preclinical phase;
- Discuss case studies demonstrating the applications and values of preclinical PK/PD modeling within the framework of industrial and academic drug discovery and translational research efforts;
- Provided with practical hands-on training on the key aspects of preclinical PK/PD modeling; Topics include PK/PD modeling and simulation for drug target selection, mechanism-based PK/PD modeling for biomarker development, and human dose projection for both small and large molecule (e.g. antibody) compounds.
- Introduced to strategies with which to overcome challenges associated with the implementation of PK/PD modeling and simulation in drug discovery and development, including silo-structure, interdisciplinary communication and decision-making infrastructure.
|
|
|
|
|
|
BioPartnering Europe & BioPartnering China
QEII Conference Centre | London, United Kingdom
11 - 14 October 2009
BioPartnering Europe (BPE) is the largest networking conference in the UK providing 3 months of prospecting through the biopartnering.com network!
BioPartnering Europe Features:
• One-to-One Partnering Powered by biopartnering.com
Maximize your time by using biopartnering.com to prepare months ahead and to follow-up with prospects well after the conference is over. 90% of conference delegates rate BioPartnering as the best conferencing software.
• Company Presentations
BPE will present 150 of the world's most innovative companies and is one of the 'must-attend' conferences for life science partnering with an international audience of more than 1200 attendees from more than 500 companies.
• Exhibition: Spotlight on Biotechnology
The spotlight on biotechnology exhibition is new for BPE 2009 and will feature 34 innovative biotechnology companies. Be one of the first companies to exhibit at BPE!
• Leadership Sessions & Workshops
Panels of industry leaders will offer expert advice on the critical issues impacting the pharmaceutical and biotech industries. Elevate your status as a thought-leader by sponsoring a BPE 2009 panel.
BioPartnering China Day
Include BioPartnering China (BPC) in your BPE partnering plans and experience this one-day event immediately following BPE at the QEII in London, on 14 October 2009. BPC will attract both European companies and institutions seeking expansion into China, as well as Chinese companies seeking to enter the European market. Registration for BPC is now open.
|
|
|
|
 |
 |
|
|
For Current Professional Development Programs, please go to the BioMelbourne Network Website |
|
New Member Deal from SAE Creative |
|
